Skip to main content

Advertisement

Log in

Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy

  • Economics and Policy in Diabetes (AA Baig and N Laiteerapong, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Gestational diabetes (GDM) is associated with adverse pregnancy and neonatal outcomes and increased maternal risk for subsequent type 2 diabetes. The best diagnostic strategy for GDM is debated and the role of oral antidiabetic medications (OAD) for treatment is unclear. In this paper, we review methods of GDM diagnosis, updates in GDM therapy, and interventions to reduce future type 2 diabetes in women with a history of GDM.

Recent Findings

A “one-step” screening protocol for GDM using 75-g, 2-h oral glucose tolerance testing at 24–28 weeks gestation is recommended by the International Association of the Diabetes and Pregnancy Study Groups, the American Diabetes Association, and the Endocrine Society. This strategy identifies a milder degree of hyperglycemia and thus increases GDM prevalence. Studies indicate that in these cases of mild hyperglycemia, treatment decreases pregnancy and neonatal complications. Insulin analogues including detemir, aspart, and lispro have been shown to be safe in pregnancy with a pregnancy category B classification. Growing literature suggests that sulfonylureas cross the placenta and are associated with increased incidence of macrosomia and neonatal hypoglycemia. Telephone or online diabetes prevention program (DPP)-based interventions for women with GDM have shown encouraging results in pilot studies. Insurance coverage remains a barrier.

Summary

Additional studies are needed to determine the safety of OAD in pregnancy. Public policy supporting DPP could help improve patient access to these proven interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27. https://doi.org/10.2337/dc18-S002. Key recommendations from an ADA multidisciplinary expert committee for classification and diagnosis of diabetes, updated yearly.

    Article  Google Scholar 

  2. Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, et al. Screening and diagnosing gestational diabetes mellitus. Evidence report/technology assessment no. 210. (prepared by the University of Alberta Evidence-based Practice Center under contract no. 290–2007-10021-I.) AHRQ Publication No. 12(13)-E021-EF. Agency for Healthcare Research and Quality: Rockville; 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm

    Google Scholar 

  3. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care. 2007;30(Suppl 2):S169–74. https://doi.org/10.2337/dc07-s211 Review. Erratum in: Diabetes Care. 2007 Dec;30(12):3154.

    Article  PubMed  Google Scholar 

  4. International Diabetes Federation. IDF diabetes atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017. http://www.diabetesatlas.org. Accessed 10 December 2018

    Google Scholar 

  5. • Deputy NP, Kim SY, Conrey EJ, Bullard KM. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth — United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1201–7. https://doi.org/10.15585/mmwr.mm6743a2. This report analyzes US vital statistics data to provide estimates about the overall prevalence of GDM in 2016 and prevalence for different races/ethnicities and BMI categories.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Booker WA, Gyamfi-Bannerman C, Sheen JJ, Wright JD, Siddiq Z, D'Alton ME, et al. Maternal outcomes by race for women aged 40 years or older. Obstet Gynecol. 2018;132(2):404–13. https://doi.org/10.1097/AOG.0000000000002751.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014;37(12):3172–9. https://doi.org/10.2337/dc14-1036.

    Article  PubMed  Google Scholar 

  8. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(Suppl 2):S112–9 Erratum in: Diabetes Care. 2007 Dec;30(12):3154.

    Article  CAS  PubMed  Google Scholar 

  9. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11). https://doi.org/10.3390/ijms19113342.

    Article  PubMed Central  Google Scholar 

  10. Kleinberger JW, Maloney KA, Pollin TI. The genetic architecture of diabetes in pregnancy: implications for clinical practice. Am J Perinatol. 2016;33(13):1319–26.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Martin-Montalvo A, López-Noriega L, Jiménez-Moreno C, Herranz A, Lorenzo PI, Cobo-Vuilleumier N, et al. Transient PAX8 expression in islets during pregnancy correlates with β-cell survival, revealing a novel candidate gene in gestational diabetes mellitus. Diabetes. 2019;68(1):109–18. https://doi.org/10.2337/db18-0285.

    Article  CAS  PubMed  Google Scholar 

  12. Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, Ellard S, et al. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care. 2015;38(7):1383–92. https://doi.org/10.2337/dc14-2769.

    Article  CAS  PubMed  Google Scholar 

  13. Badon SE, Zhu Y, Sridhar SB, Xu F, Lee C, Ehrlich SF, et al. A pre-pregnancy biomarker risk score improves prediction of future gestational diabetes. J Endocr Soc. 2018;2(10):1158–69. https://doi.org/10.1210/js.2018-00200.

    Article  PubMed  PubMed Central  Google Scholar 

  14. •• Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131(2):e49–64. https://doi.org/10.1097/AOG.0000000000002501. Key guidelines from ACOG for GDM diagnosis and management with specific updates on pharmacologic treatment of GDM.

    Article  Google Scholar 

  15. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. https://doi.org/10.1056/NEJMoa0707943.

    Article  Google Scholar 

  16. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. https://doi.org/10.2337/dc09-1848.

    Article  CAS  PubMed Central  Google Scholar 

  17. Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(11):4227–49. https://doi.org/10.1210/jc.2013-2465.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. • Waters TP, Dyer AR, Scholtens DM, Dooley SL, Herer E, Lowe LP, et al. Maternal and neonatal morbidity for women who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the Hyperglycemia and Adverse Pregnancy Outcome Study. Diabetes Care. 2016;39(12):2204–10. A secondary analysis of HAPO study participants which observed higher rates of adverse pregnancy outcomes for women diagnosed with GDM based on IADPSG criteria compared to women with no GDM.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. 2012;35(3):526–8. https://doi.org/10.2337/dc11-1641.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–48. https://doi.org/10.1056/NEJMoa0902430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86.

    Article  CAS  PubMed  Google Scholar 

  22. Werner EF, Pettker CM, Zuckerwise L, Reel M, Funai EF, Henderson J, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care. 2012;35(3):529–35. https://doi.org/10.2337/dc11-1643.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Vandorsten JP, Dodson WC, Espeland MA, Grobman WA, Guise JM, Mercer BM, et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements. 2013;29(1):1–31.

    PubMed  Google Scholar 

  24. • American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S137–43. https://doi.org/10.2337/dc18-S013. Key recommendations from an ADA multidisciplinary expert committee for management of type 1, type 2, and GDM in pregnancy and post-partum, updated yearly.

    Article  Google Scholar 

  25. Viana LV, Gross JL, Azevedo MJ. Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care. 2014;37(12):3345–55. https://doi.org/10.2337/dc14-1530.

    Article  PubMed  Google Scholar 

  26. Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009. Schwartz RA, Rosenn B, Aleksa K, Koren G. Glyburide transport across the human placenta. Obstet Gynecol 2015 Mar;125(3):583–8. doi: https://doi.org/10.1097/AOG.0000000000000672

    Article  CAS  Google Scholar 

  27. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30(Suppl 2):S251–60. https://doi.org/10.2337/dc07-s225 Erratum in: Diabetes Care. 2007 Dec;30(12):3154.

    Article  CAS  PubMed  Google Scholar 

  28. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333(19):1237–41.

    Article  PubMed  Google Scholar 

  29. Nielsen LR, Ekbom P, Damm P, Glümer C, Frandsen MM, Jensen DM, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;27(5):1200–1.

    Article  CAS  PubMed  Google Scholar 

  30. Farrar D, Tuffnell DJ, West J, West HM. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev. 2016;6:CD005542. https://doi.org/10.1002/14651858.CD005542.pub3.

    Article  Google Scholar 

  31. • Herrera KM, Rosenn BM, Foroutan J, Bimson BE, Al Ibraheemi Z, Moshier EL, et al. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes. Am J Obstet Gynecol. 2015;213(3):426.e1–7. https://doi.org/10.1016/j.ajog.2015.06.010. This RCT demonstrated that insulin detemir was non-inferior to NPH for glycemic control and perinatal/neonatal outcomes.

    Article  CAS  Google Scholar 

  32. Koren R, Toledano Y, Hod M. The use of insulin detemir during pregnancy: a safety evaluation. Expert Opin Drug Saf. 2015;14(4):593–9. https://doi.org/10.1517/14740338.2015.1013533.

    Article  PubMed  Google Scholar 

  33. Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a meta-analysis. Arch Gynecol Obstet. 2015;292(4):749–56. https://doi.org/10.1007/s00404-015-3692-3.

    Article  CAS  PubMed  Google Scholar 

  34. • Blum AK. Insulin use in pregnancy: an update. Diabetes Spectr. 2016;29(2):92–7. https://doi.org/10.2337/diaspect.29.2.92 Erratum in: Diabetes Spectr. 2016 Aug;29(3):191. Review of the use of insulin in pregnancy and safety of different insulin formulations including FDA pregnancy categories.

    Article  PubMed  PubMed Central  Google Scholar 

  35. •• Jiang YF, Chen XY, Ding T, Wang XF, Zhu ZN, Su SW. Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2015;100(5):2071–80. https://doi.org/10.1210/jc.2014-4403. A meta-analysis of 18 RCTs which showed similar glycemic control with insulin, metformin, and glyburide but increased incidence of neonatal hypoglycemia and macrosomia with glyburide.

    Article  CAS  PubMed  Google Scholar 

  36. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–15. https://doi.org/10.1056/NEJMoa0707193 Erratum in: N Engl J Med. 2008 Jul 3;359(1):106.

    Article  CAS  PubMed  Google Scholar 

  37. • Schwartz RA, Rosenn B, Aleksa K, Koren G. Glyburide transport across the human placenta. Obstet Gynecol. 2015;125(3):583–8. https://doi.org/10.1097/AOG.0000000000000672. Prospective study which demonstrated transplacental transfer of glyburide occurs and is highly variable among patients.

    Article  CAS  PubMed  Google Scholar 

  38. Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril. 2005;83(5):1575–8.

    Article  PubMed  Google Scholar 

  39. Kjos SL, Leung A, Henry OA, Victor MR, Paul RH, Medearis AL. Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol. 1995;173(5):1532–9.

    Article  CAS  PubMed  Google Scholar 

  40. Gabbe SG, Mestman JG, Freeman RK, Anderson GV, Lowensohn RI. Management and outcome of class A diabetes mellitus. Am J Obstet Gynecol. 1977;127(5):465–9.

    Article  CAS  PubMed  Google Scholar 

  41. Casey BM, Lucas MJ, Mcintire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol. 1997;90(6):869–73.

    Article  CAS  PubMed  Google Scholar 

  42. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA. 1996;276(18):1480–6.

    Article  CAS  PubMed  Google Scholar 

  43. Johnstone FD, Prescott RJ, Steel JM, Mao JH, Chambers S, Muir N. Clinical and ultrasound prediction of macrosomia in diabetic pregnancy. Br J Obstet Gynaecol. 1996;103(8):747–54.

    Article  CAS  PubMed  Google Scholar 

  44. Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2. Am J Perinatol. 1996;13(5):293–6.

    Article  CAS  PubMed  Google Scholar 

  45. Witkop CT, Neale D, Wilson LM, Bass EB, Nicholson WK. Active compared with expectant delivery management in women with gestational diabetes: a systematic review. Obstet Gynecol. 2009;113(1):206–17. https://doi.org/10.1097/AOG.0b013e31818db36f.

    Article  PubMed  Google Scholar 

  46. • Alberico S, Erenbourg A, Hod M, Yogev Y, Hadar E, Neri F, et al. Immediate delivery or expectant management in gestational diabetes at term: the GINEXMAL randomised controlled trial. BJOG. 2017;124(4):669–77. https://doi.org/10.1111/1471-0528.14389. Multicenter RCT which showed no difference in rates of cesarean section or complications for women with uncomplicated GDM randomized to induction of labor at 38–39 weeks versus expectant management (note that intended sample size was not achieved).

    Article  CAS  PubMed  Google Scholar 

  47. Rosenberg VA, Eglinton GS, Rauch ER, Skupski DW. Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am J Obstet Gynecol. 2006;195(4):1095–9.

    Article  CAS  PubMed  Google Scholar 

  48. Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and incidence of type 2 diabetes. JAMA. 2005;294(20):2601–10.

    Article  CAS  PubMed  Google Scholar 

  49. Nam GE, Han K, Kim DH, Huh Y, Han B, Cho SJ, et al. Associations between Breastfeeding and Type 2 Diabetes Mellitus and Glycemic Control in Parous Women: A Nationwide, Population-Based Study. Diabetes Metab J. 2019;43(2):236-241. https://doi.org/10.4093/dmj.2018.0044. Accessed 21 Dec 2018.

    Article  Google Scholar 

  50. Horta BL, de Lima NP. Breastfeeding and type 2 diabetes: systematic review and meta-analysis. Curr Diab Rep. 2019;19(1):1. https://doi.org/10.1007/s11892-019-1121-x.

    Article  PubMed  Google Scholar 

  51. Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009;301(8):842–7. https://doi.org/10.1001/jama.2009.201.

    Article  CAS  PubMed  Google Scholar 

  52. Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol. 1990;163(1 Pt 1):93–8.

    Article  CAS  PubMed  Google Scholar 

  53. Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165(4 Pt 1):914–9.

    Article  CAS  PubMed  Google Scholar 

  54. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–8.

    Article  PubMed  Google Scholar 

  55. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9. https://doi.org/10.1016/S0140-6736(09)60731-5.

    Article  CAS  PubMed  Google Scholar 

  56. • Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women. Diabetes Res Clin Pract. 2018;141:200–8. https://doi.org/10.1016/j.diabres.2018.05.010. A study of NHANES data which assessed prevalence of GDM and subsequent diabetes and identified associated sociodemographic and health-related characteristics associated with these outcomes.

    Article  PubMed  Google Scholar 

  57. Getahun D, Fassett MJ, Jacobsen SJ. Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol. 2010;203(5):467.e1–6. https://doi.org/10.1016/j.ajog.2010.05.032.

    Article  Google Scholar 

  58. Hedderson M, Ehrlich S, Sridhar S, Darbinian J, Moore S, Ferrara A. Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI. Diabetes Care. 2012;35(7):1492–8. https://doi.org/10.2337/dc11-2267.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Kieffer EC, Carman WJ, Gillespie BW, Nolan GH, Worley SE, Guzman JR. Obesity and gestational diabetes among African-American women and Latinas in Detroit: implications for disparities in women’s health. J Am Med Womens Assoc (1972). 2001;56(4):181–7 196.

    CAS  Google Scholar 

  60. Singh H, Soyoltulga K, Fong T, Billimek J. Delivery outcomes, emergency room visits, and psychological aspects of gestational diabetes: results from a community hospital multiethnic cohort. Diabetes Educ. 2018;44(5):465–74. https://doi.org/10.1177/0145721718795589.

    Article  PubMed  Google Scholar 

  61. Stasenko M, Cheng YW, McLean T, Jelin AC, Rand L, Caughey AB. Postpartum follow-up for women with gestational diabetes mellitus. Am J Perinatol. 2010;27(9):737–42. https://doi.org/10.1055/s-0030-1253557.

    Article  PubMed  Google Scholar 

  62. • Oza-Frank R, Conrey E, Bouchard J, Shellhaas C, Weber MB. Healthcare experiences of low-income women with prior gestational diabetes. Matern Child Health J. 2018;22(7):1059–66. https://doi.org/10.1007/s10995-018-2489-y. This study conducted focus groups with a diverse sample of women with history of GDM to identify barriers to GDM care, management, and follow-up.

    Article  PubMed  Google Scholar 

  63. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774–9. https://doi.org/10.1210/jc.2008-0772.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Pastore I, Chiefari E, Vero R, Brunetti A. Postpartum glucose intolerance: an updated overview. Endocrine. 2018;59(3):481–94. https://doi.org/10.1007/s12020-017-1388-0.

    Article  CAS  PubMed  Google Scholar 

  65. Ferrara A, Peng T, Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care. 2009;32(2):269–74. https://doi.org/10.2337/dc08-1184.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Lawrence JM, Black MH, Hsu JW, Chen W, Sacks DA. Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care. 2010;33(3):569–76. https://doi.org/10.2337/dc09-2095.

    Article  PubMed  Google Scholar 

  67. Venkataramani M, Pollack CE, Yeh HC, Maruthur NM. Prevalence and Correlates of Diabetes Prevention Program Referral and Participation. Am J Prev Med. 2019;56(3):452-457. https://doi.org/10.1016/j.amepre.2018.10.005. Accessed 17 Jan 2019.

    Article  PubMed  Google Scholar 

  68. Ferrara A, Hedderson MM, Albright CL, Ehrlich SF, Quesenberry CP Jr, Peng T, et al. A pregnancy and postpartum lifestyle intervention in women with gestational diabetes mellitus reduces diabetes risk factors: a feasibility randomized control trial. Diabetes Care. 2011;34(7):1519–25. https://doi.org/10.2337/dc10-2221.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Gómez ML, Hieronymus LB, Ashford KB, Barnett JM, Renn TA. Linking postpartum and parenting women with a National Diabetes Prevention Program: recruitment efforts, challenges, and recommendations. Diabetes Spectr. 2018;31(4):324–9. https://doi.org/10.2337/ds18-0013.

    Article  PubMed  PubMed Central  Google Scholar 

  70. • Handley MA, Harleman E, Gonzalez-Mendez E, Stotland NE, Althavale P, Fisher L, et al. Applying the COM-B model to creation of an IT-enabled health coaching and resource linkage program for low-income Latina moms with recent gestational diabetes: the STAR MAMA program. Implement Sci. 2016;11(1):73. https://doi.org/10.1186/s13012-016-0426-2. This paper describes an intervention for Latina women with a history of GDM using a bilingual, telephone-based health coaching program adapted from the DPP.

    Article  PubMed  PubMed Central  Google Scholar 

  71. McCurley JL, Fortmann AL, Gutierrez AP, Gonzalez P, Euyoque J, Clark T, et al. Pilot test of a culturally appropriate diabetes prevention intervention for at-risk Latina women. Diabetes Educ. 2017;43(6):631–40. https://doi.org/10.1177/0145721717738020.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Preventive care benefits for women. HealthCare.gov. https://www.healthcare.gov/preventive-care-women/. Accessed 31 Jan 2019.

  73. Medicaid Coverage. National Diabetes Prevention Program Coverage Toolkit. https://coveragetoolkit.org/medicaid-agencies/medicaid-coverage-2/ (2019). Accessed 1 Feb 2019.

  74. Evans M, Schumm-Draeger PM, Vora J, King AB. A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes Obes Metab. 2011;13(8):677–84. https://doi.org/10.1111/j.1463-1326.2011.01395.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (grant number T32 DK0070110).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura T. Dickens.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Economics and Policy in Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dickens, L.T., Thomas, C.C. Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. Curr Diab Rep 19, 33 (2019). https://doi.org/10.1007/s11892-019-1147-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-019-1147-0

Keywords

Navigation